Health
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study – News-Medical.Net
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with…
Recent research indicates the occurrence of thromboembolic complications involving anti-phospholipid antibodies (APLA) and the anti-phospholipid syndrome (APS) in severe coronavirus disease 2019 (COVID-19). However, conflicting reports have emerged.
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.
The team have released their findings as a preprint…
-
Noosa News19 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General21 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Noosa News23 hours agoBrisbane Man crushed and seriously injured by metal beam in workplace accident at Logan
-
Noosa News22 hours agoVHM’s Goschen Rare Earths and Mineral Sands Project granted 20-year licence